TGF-β Is Required for Vascular Barrier Function, Endothelial Survival and Homeostasis of the Adult Microvasculature by Walshe, Tony E. et al.
TGF-b Is Required for Vascular Barrier Function,




., Arindel S. R. Maharaj, Eiichi Sekiyama, Angel E. Maldonado,
Patricia A. D’Amore*
Departments of Ophthalmology and Pathology, Harvard Medical School, Schepens Eye Research Institute, Boston, Massachusetts, United States of America
Abstract
Pericyte-endothelial cell (EC) interactions are critical to both vascular development and vessel stability. We have previously
shown that TGF-b signaling between EC and mural cells participates in vessel stabilization in vitro. We therefore investigated
the role of TGF-b signaling in maintaining microvessel structure and function in the adult mouse retinal microvasculature.
TGF-b signaling was inhibited by systemic expression of soluble endoglin (sEng) and inhibition was demonstrated by
reduced phospho-smad2 in the adult retina. Blockade of TGF-b signaling led to increased vascular and neural cell apoptosis
in the retina, which was associated with decreased retinal function, as measured by electroretinogram (ERG). Perfusion of
the inner retinal vasculature was impaired and was accompanied by defective autoregulation and loss of capillary integrity.
Fundus angiography and Evans blue permeability assay revealed a breakdown of the blood-retinal-barrier that was
characterized by decreased association between the tight junction proteins zo-1 and occludin. Inhibition of TGF-b signaling
in cocultures of EC and 10T1/2 cells corroborated the in vivo findings, with impaired EC barrier function, dissociation of EC
from 10T1/2 cells, and endothelial cell death, supporting the role of EC-mesenchymal interactions in TGF-b signaling. These
results implicate constitutive TGF-b signaling in maintaining the integrity and function of the adult microvasculature and
shed light on the potential role of TGF-b signaling in vasoproliferative and vascular degenerative retinal diseases.
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Introduction
Formation, stabilization and specialization of the vasculature is
a complex process that requires the coordinated action of a
number of growth factors and a variety of heterotypic cellular
interactions. Transforming growth factor-b1 (TGF-b1) is a
multifunctional growth factor that is a well-established modulator
of vascular cells [1]. In vitro studies indicate that TGF-b1i s
activated upon contact between endothelial and mesenchymal
cells [2] and that it mediates a variety of actions associated with
vessel maturation including, inhibition of EC proliferation and
migration, induction of pericyte differentiation, and production of
basement membrane [2–4]. These observations suggest that local
activation of TGF-b1 in vivo may be critical to vessel remodeling
and stability.
The retinal microvasculature, the site of the inner blood retinal
barriers, is one of the most stable microvascular beds in the body
with EC turnover rates estimated in years [5]. Pericytes envelop
EC tubes and are present at different pericyte-EC ratios depending
upon the microvessel bed [6,7]. Trypsin digests of the retinal
vasculature have revealed a ratio of pericytes to ECs roughly
equaled to 1, whereas ECs outnumber pericytes in other
microvascular beds by as much as 10 to 1 [6]. In vitro studies
demonstrate that contact between ECs and pericytes or astrocytes
leads to TGF-b1 activation, a major determinant of TGF-b1
availability and signaling [8]. Moreover, the loss of retinal
pericytes has been speculated to be permissive for the progression
of diabetic retinopathy [9]. Taken together, these observations
have led us to speculate that the high number of pericytes in the
retina reflects a significant role for constitutive TGF-b1 signaling
in maintenance of retinal microvascular integrity.
Binding of TGF-b1 dimers to TGFb-receptor II (TGFbRII)
leads to the recruitment of TGFb-receptor I (TGFbRI), the
formation of a tetrameric complex, phosphorylation and confor-
mational changes in the intracellular domain of TGFbRI, and
downstream activation of smad transcription factors. Most cell
types express only one TGFbRI receptor, ALK5 [10]. In ECs,
TGF-b1 activation of ALK5 is growth inhibitory and is thought to
mediate vessel stability [10]. ECs also express the TGFbRI
receptor ALK1, as well as the TGF-b1 co-receptor endoglin (also
referred to as TGFbRIII). In contrast to ALK5 signaling, TGF-b1
signaling via endoglin or ALK-1 on ECs is associated with vessel
destabilization, EC proliferation and migration, by limiting TGF-
b1-ALK5 EC signaling [11]. Consistent with these findings,
increased endoglin is a defining feature of proliferating vessels
in tumors and is a current target for anti-cancer treatments
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cd105&rank=1) [12].
The phenotypes of mice deficient in TGF-b1 and of naturally
occurring mutations of TGF-b1 pathway support a role for
TGF-b1 in formation and maintenance of the vasculature.
Targeted deletion of alk1, alk5, TGFbRII, endoglin and smad5 are
all embryonic lethal, each with comparable cardiovascular
defects, with some subtle differences [13]. TGFbRII null mice
die around mid-gestation from defective yolk sac vascularization
and hematopoiesis [14], whereas mice deficient in TGFbRI have
defective yolk sac vasculogenesis, but normal hematopoiesis [15].
In humans, heterozygous mutations of either endoglin or alk1
cause hereditary hemorrhagic telangiectasia (HHT)-1 or HHT-
2, respectively, both characterized by vascular anomalies such as
dilated vessels, edema, arterio-venous malformations, and
pulmonary, liver and neurological problems due to vascular
defects [16].
Systemic inhibition of TGF-b and VEGF, as a result of high
levels of circulating placental derived soluble endoglin (sEng) and
soluble fms-like tyrosine kinase 1 (sFlt1), respectively, have been
reported to be involved in the pathogenesis of preeclampsia [17].
Preeclampsia is a condition of pregnancy characterized by
systemic endothelial dysfunction, multiple end-organ ischemia,
hypertension and proteinuria - a phenotype that is largely
recapitulated by systemic inhibition of TGF-b and VEGF in
pregnant rats [17]. Additionally, preeclampsia is associated with
increased vascular permeability [18].
One consequence of reduced circulating TGF-b and VEGF is a
decrease in endothelial formation of nitric oxide (NO) [17], a
potent vasoactive molecule with anti-thrombogenic effects. Recent
evidence demonstrates that administration of TGF-b1 can induce
arteriogenesis in the peripheral circulation [19], however the role
of endogenous TGF-b1 signaling in the quiescent adult microvas-
culature has not been defined. Therefore, we have examined the
effects of systemic TGF-b inhibition on perfusion, permeability
and function of adult microvasculature, using the retinal
microvasculature as an easily accessible and clinically relevant
model. The unique structure of the retina enables structural and
functional analysis of microvessels in vivo, which are not feasible
with other microvessel beds. In addition, we used an in vitro
coculture system to identify the effects of TGF-b1 blockade on
ECs and 10T1/2 cells (as mesenchymal precursors of pericytes)
[20].
Results
Systemic inhibition of TGF-b decreases smad2
phosphorylation in the retina
RT-PCR of cDNA collected from adult mouse retinas revealed
the expression of smad2, smad3, TGF-b1 and TGF-b3 (Figure 1A).
To evaluate the role of endogenous TGF-b signaling in vivo,
adenovirus of Ad-sEng was used to systemically inhibit TGF-b
signaling in mice; control mice included non-infected mice
(Figure 1B) and mice infected with an Ad-null virus (Figure 1C).
sEng binds both TGF-b1 and TGF-b3. In the retina, TGF-b1i s
associated with endothelial, mural and microglial cells, whereas
TGF-b3 is expressed mainly by ganglion and microglial cells [21–
23]. One of the earliest events of TGF-b signal activation is
phosphorylation of smad2 and its translocation to the nucleus [24].
We used immunohistochemistry for pp-smad2 to localize the cell
types with active TGF-b signaling in the retina. In both control
and treated mice, nuclear pp-smad2 was evident in the neurons of
the ganglion cell layer (Figure 1C; arrows); the inner nuclear layer
(INL), which contains bipolar, amacrine and horizontal cells
(arrowheads); and, EC and mural cells (Figure 1D). The staining
intensity of pp-smad2 was reproducibly reduced in Ad-sEng-
expressing mice as compared to control mice (Figure 1C). Western
blot analysis for pp-smad2 on whole retina lysates indicated a
marked reduction of smad2 phosphorylation in Ad-sEng mice
compared to the control after seven days (Figure 1E; Figure 1F
quantification), demonstrating that systemic expression of sEng
effectively neutralizes TGF-b signaling. No changes in total smad2
or phosphorylation of smad1/5/8 were noted after seven days of
TGF-b neutralization (Figure 1E).
Inhibition of TGF-b decreases retinal perfusion and
impairs peripheral vascular autoregulation
TGF-b1 regulates endothelial synthesis of numerous vasoactive
agents such as NO and endothelin-1 [25]. To examine the effect of
TGF-b1 blockade on microvascular perfusion, mice were perfused
with high molecular weight FITC-dextran 14 days post adenovirus
infection. Abnormal perfusion was apparent in retinal flat-mount
preparations from sEng-expressing mice (Figure 2A), and co-
staining for type IV collagen, a component of the capillary
basement membrane, confirmed a lack of perfusion in some vessels
of sEng expressing mice (Figure 2B). Microvascular perfusion was
quantified on serial cryosections of dextran-perfused retinas.
Though there was no change in the density of type IV collagen-
positive vessels in the retinas of sEng-expressing mice compared to
control mice, numerous of the type IV collagen-positive were
FITC-dextran negative (Figure 2C), indicating non-perfusion.
Quantification of the collagen and dextran-positive vessels in the
inner layers of the retina confirmed a significant (approx. 25%)
reduction in vascular perfusion in sEng-expressing mice
(Figure 2D).
The retinal microvasculature maintains perfusion by autoreg-
ulation, where endothelial-derived NO induces mural cell
relaxation thereby increasing local blood flow [26]. As altered
peripheral blood flow is often used as a surrogate for retinal
microvascular dysfunction [27], we monitored blood flow rates in
the tail vasculature. Acetylcholine (ACh), an endothelium-
dependent vasodilator, led to increased blood flow in control
mice but not in sEng-expressing mice, indicating impaired
endothelial vasoactive capacity (Figure 2E).
TGF-b inhibition causes reduced endothelial barrier
function in vivo and in vitro
Similar to the blood-brain-barrier, the retinal vasculature forms
the blood-retinal barrier (BRB), which protects neural retina from
neurotransmitters and potentially damaging circulating factors.
Barrier function in vivo was examined by fundus angiography.
Whereas vessels in Ad-null control mice were well-defined and did
notexhibitevidenceoffluoresceinleakage,vesselsofsEng-expressing
mice appeared more diffuse due to a more rapid leakage of the dye
(Figure 3A). In parallel experiments, extravasated Evans blue was
quantifiedand confirmedabreakdownoftheblood-retinalbarrierin
sEng-expressing mice (Figure 3B).
Barrier function is mediated by tight and adherens barrier
proteins between adjacent ECs. Transmission electron micros-
copy (TEM) analysis of the superficial vascular plexus in sEng-
expressing mice revealed structural alterations in tight junctions
between microvascular ECs (Figure 3C). The tight junction
proteins zo-1 and occludin constitute a major aspect of the
blood retinal barrier [28]. Immunoprecipitation of occludin,
followed by western blotting for zo-1, revealed a decrease in
association between these two proteins in sEng-expressing mice
(Figure 3D).
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function, we utilized Transwell cocultures of EC and 10T1/2
cells (as undifferentiated mesenchymal pericyte precursors),
which mimic the in vivo interaction between EC and mural
cells and which we have shown leads to local activation of
TGF-b1 [20]. Using a smad2/3 luciferase reporter construct
(CAGA-Luc), we demonstrated activation of smad2/3 signaling
in ECs in co-culture with 10T1/2 cells compared to EC mono-
cultures (Figure 4A). Addition of SB-431542, a pharmacolog-
ical inhibitor of TGFbRI /ALK5, reversed the co-culture effect
of co-culture, but did not significantly alter baseline smad2/3
luciferase in EC mono-cultures or phosphorylation of smad1/
5/8, downstream transcription factors of the TGF-bR1 –
ALK1 (Figure 4B).
Scanning electron microscopy (SEM) revealed enhanced
association between adjacent ECs co-cultured with 10T1/2 cells
(Figure 5A) and the size of EC in the co-cultures was more uniform
than that of EC cultured alone (Figure 5B). The role of TGF-b1
signaling was assessed using SB-431542. Addition of SB-431542 to
co-cultures reversed the co-culture-induced effects on interen-
dothelial association (Figure 5A) and led to a reversion to
heterogeneous EC cell sizes (Figure 5B). In contrast to changes
in EC shape that were evident in co-culture with 10T1/2’s, SEM
analysis of 10T1/2’s morphology revealed no obvious difference in
their morphology whether in mono-culture, co-culture, or in the
presence of SB-431542 (Figure 5A).
Immunoprecipitation of occludin followed by western blotting
for zo-1 revealed that coculture of EC with 10T1/2 cells led to an
increased association between occludin and zo-1 in EC, which was
significantly reduced by TGF-b1 inhibition (Figure 6A). Measure-
ment of barrier function of EC in Transwell by the permeability of
the EC layer to 40-kDa FITC-conjugated dextran [28] revealed
that coculture of ECs with the 10T1/2 cells enhanced EC barrier
function compared to that of ECs alone (Figure 6B). The reduction
in permeability by the ALK5 inhibitor SB-431542 further
implicates ALK5 signaling in the maintenance of EC barrier
function.
Effect of TGF-b inhibition on the ultrastructure of the
retinal vasculature
TEM of capillaries in the ganglion cell layer of mice expressing
Ad-null revealed normal ultrastructure, with close apposition
between ECs and pericytes, a defined extracellular space, and few
vacuoles (Figure 7A). In contrast, retinal microvessels of sEng-
expressing mice were characterized by multiple abnormalities,
particularly in the superficial vascular plexus. The luminal surface
of some ECs exhibited a ruffled appearance, with luminal
projections and increased vacuoles (Figure 7B). Nuclear conden-
sation associated with apoptosis was apparent in some, but not all
pericytes (Figure 7C) and ECs (Figure D), and, consistent with our
findings of non-perfusion and impaired NO formation in sEng
expressing mice, many vessels appeared completely or partially
collapsed (Figures 7E and 7F).
TGF-b inhibition leads to morphological and functional
changes in neural retina
TUNEL staining revealed an increase in the number of
apoptotic cells in the ganglion cells layer, the inner, and outer
nuclear layers of the retina (Figure 8A). Increased apoptosis in
sEng-expressing mice was supported by a significant increase in
cleaved-caspase 3 by western blot analysis of whole retinas
(Figure 8B and 8C).
To determine if the reduced retinal perfusion in sEng-expressing
mice was associated with retinal dysfunction, the electrical
response of the retina to a light stimulus was measured via
electroretinogram (ERG). Although the exact origin and genera-
tion of ERG waves remain incompletely understood, it is well
accepted that the negative a-wave originates primarily from
photoreceptor cells and the positive b-wave derives from the
electrical response between photoreceptor cells and neural cells in
the inner retina such as bipolar and amacrine cells [29]. Full-field
ERG of Ad-null expressing control mice displayed baseline a- and
b-wave amplitudes (Figure 9A). Analysis of sEng-expressing mice
seven days after virus administration exhibited a-wave amplitude
similar to Ad-null infected control, whereas the b-wave amplitude
was significantly decreased (687.1+/231.68 vs. 524.2+/229.85)
(Figure 9B).
Examination of the structural integrity of the neural retina by
TEM revealed that TGF-b neutralization led to increased
apoptosis of ganglion cells and neural cells of the INL and ONL
(Figure 8C). Apoptotic Mu ¨ller and amacrine cells were identified
based on their morphology and location in the INL [30]. Ganglion
cell, Mu ¨ller cell and amacrine cell apoptosis in Ad-sEng mice was
evidenced by condensed nuclei, cellular shrinkage and membrane
blebbing. Photoreceptor cell nuclei displayed similar features of
apoptosis and separation from the surrounding matrix in some,
but not all mice. Axons beneath the ganglion cells were swollen,
with apparent rupture of mitochondria.
Inhibition of TGF-b1 signaling in EC - mesenchymal cell
coculture leads to increased EC apoptosis
Since TGF-b1 acts on both EC and 10T1/2 cells via TGFbRI /
ALK5 [2], we assessed the effects of inhibiting TGF-b1 signaling
in Transwell cocultures. Whereas EC apoptosis was similar in
mono-cultures of ECs and in EC-10T1/2 cell co-cultures, addition
of SB-431542 increased endothelial apoptosis in the cocultures,
but not in EC alone, suggesting that activated TGF-b1 is a survival
signal for ECs (Figure 10A). Although 10T1/2 cell apoptosis was
significantly decreased by coculture with EC; inhibition of TGF-b
signaling with SB-431542 did not alter 10T1/2 cell apoptosis in
the cocultures (Figure 10B), indicating that TGF-b1 does not
mediate the increased mesenchymal cell survival observed in EC-
10T1/2 cell cocultures.
In order to determine the mechanism of TGF-b1’s anti-
apoptotic effect on ECs, we examined cleavage of caspase 3, a key
step in the apoptotic cascade, and the BCl-2 family of proteins,
which also plays a role in apoptosis. Addition of SB-431542
Figure 1. Systemic inhibition of TGF-b decreases retinal smad2 phosphorylation in vivo. (A) RT-PCR of adult murine retinal cDNA revealed
the presence of smad2, smad3, TGF-b1 and TGF-b3. Lanes one and two are two retinal cDNA preparations. Lane three is a negative control with no RT
enzyme. Immunohistochemical localization of pp-smad2 in retinas from (B) control (non infected animals) and (C) Ad-null and Ad-sEng-expressing
mice (day 7) revealed pp-smad2 staining in nuclei of the ganglion cell layer (arrows) and the INL (arrowheads). sEng expression led to a decrease in
the intensity of pp-smad2 staining. Scale=50 mm. (D) Higher magnification of ppsmad2 staining in control mice, demonstrating nuclear pp-smad2 in
retinal ECs (arrow). Scale=20 mm. (E) Western blot analysis of pp-smad2, smad2, pp-smad1/5/8 and GAPDH in mouse retinas from Ad-null and Ad-
sEng-expressing mice (day 7). sEng-expressing mice displayed a decrease in retinal pp-smad2 (F). Each lane corresponds to a protein preparation
from one mouse retina. Quantification of ppsmad2 (n=4, * p,0.05).
doi:10.1371/journal.pone.0005149.g001
TGF-b Signaling in the Retina
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cells (Figure 10C), whereas no change in cleavage of caspase 3 was
detected between ECs from mono- or co-culture. In contrast,
addition of SB-431542 decreased EC BCl-xl protein levels
(Figure 10D).
To assess the role of TGF-b1 on EC-10T1/2 interactions in a
three-dimensional coculture model, EC were cocultured with
fluorescently pre-labeled 10T1/2 cells in Matrigel. EC formed
tube-like structures, with the 10T1/2 cells associating with the
endothelial abluminal surface and mimicking their association in
vivo (Figure 10E). Addition of SB-431542 led to the dissociation of
10T1/2 cells from the EC, a reduction in the number of EC tubes
(Figure 10D), and increased apoptosis of EC but not of 10T1/2
(Figure 10F).
Discussion
Our findings reveal the existence of a constitutive TGF-b
signaling in adult mouse retina required for the survival of both
vascular and neural cells. Systemic inhibition of TGF-b led to
numerous abnormalities in the retinal microcirculation, with
impaired perfusion of the superficial vascular plexus and vascular
leakage. These findings are consistent with the expression of TGF-
b1 by pericytes and ECs of the human retinal microvasculature
[23], the requirement for TGF-b1 and its receptors in formation of
the vasculature [14,15]. Further, these observations support our
hypothesis that the relatively high ratio of pericytes to EC in the
retina, compared to other vessel beds, should lead to significant
activation of latent TGF-b1.
TEM analysis of retinas from sEng-expressing mice revealed
collapsed vessels, consistent with an impaired capacity to form NO
and to autoregulate flow. Coherent with this notion, NOS3, the
enzyme required for constitutive NO formation in ECs has been
shown to be downregulated in ECs harvested from HHT patients
[31], a pathology due to heterozygous mutations in either endoglin
or Alk1 and characterized by multiple vascular malformations.
NO facilitates blood flow by acting upon the endothelium to
maintain a non-thrombogenic surface. In addition, NO-induced
contraction and relaxation of pericytes may regulate lumen size
and thereby control capillary perfusion [32], functions supported
by pericyte expression of the muscle isoforms of actin, myosin and
tropomyosin [7]. As Pousielle’s law dictates, minor changes in
caliber of very small diameter capillaries would lead to significant
alterations in blood flow. The high ratio of pericytes to ECs in the
retina and brain may be of particular importance in regulating
local blood flow because the microvasculature of the CNS lacks
autonomic innervation and precapillary sphincters, which con-
tribute to autoregulation in other microvascular beds [33].
During new vessel assembly, mesenchymal cells are recruited to
forming capillary tubes via EC-derived PDGF-B, a process that
has been demonstrated both in vitro and in vivo [3,34]. Coculture
studies have demonstrated that contact between these two cell
types induces mesenchymal cell differentiation into mural cell
phenotype and suppression of endothelial cell proliferation and
migration - processes dependent upon TGF-b1 [2,3,35]. TGF-b1
has been shown to act on ECs via one of two type I TGF-b
receptors (ALK1 & ALK5) to regulate cell fate decisions. ALK1 is
activated in angiogenesis and its expression is diminished in adult
vessels [36] whereas ALK5 mediates the anti-proliferative and
anti-apoptotic actions of TGF-b1 signaling in ECs [37]. To
understand the inhibitory effects of TGF-b1 in quiescent adult
vasculature, ECs and mesenchymal cells were cocultured in
Transwell or 3-D Matrigel in the presence of the ALK5 inhibitor
SB-431542. Previous in vitro studies have revealed significant
differences between TGF-b1 actions in conventional 2-D cell
cultures and in 3-D matrices. In 3-D culture, TGF-b1 stimulates
EC polarization, formation of zo-1 containing junctional com-
plexes, redistribution and reorganization of the existing and newly
synthesized ECM; none of these effects are seen in parallel 2-D in
vitro experiments [38]. For these reasons we compared the effect
of TGF-b1 inhibition on EC and 10T1/2 cell apoptosis in 2-D
Transwell or 3-D cocultures. In both coculture systems, inhibition
of ALK5 led to a significant increase in endothelial, but not 10T1/
2, cell death. Analysis of EC samples from Transwell revealed an
increase in cleavage of caspase 3, concomitant with a decrease in
the anti-apoptotic BCl-xL upon TGF-b1 inhibition. Consistent
with these findings, BCl-xL has previously been described as a
negative regulator of caspase 3 [39]. Previous 2-D coculture
studies found that 10T1/2 cell-derived VEGF inhibits EC
apoptosis [40], however addition of TGF-b1 can also induce
apoptosis in the absence of supporting cells, demonstrating the
effects of TGF-b1 are context-dependent [41]. Our observation
that the presence of 10T1/2 cells did not significantly alter
endothelial apoptosis may be due to the higher levels of serum
and/or culture in Matrigel, which both contain VEGF. Further-
more, ALK5 inhibition led to a significant decrease in the number
of mesenchymal cells associated with ECs in the 3-dimensional
model, suggesting that TGF-b1 is required for the continued
association between these cells. Similarly, we have showed
previously that addition of neutralizing agents (soluble TGF-bRII)
blocks cord formation and 10T1/2 differentiation [20]. Activated
TGF-b1 blocks cell migration and leads to changes in matrix level
and composition [42] [4]; both are likely to contribute to the
observed decrease in cell association in SB-431542-treated
cocultures. Our findings are consistent with observations of
background diabetic microangiopathy in which loss of vessel-
associated pericytes is thought to underlie capillary dilation as well
as breakdown of the BRB and also a decrease in active TGF-b1i n
DR [43].
Our studies demonstrate perfusion abnormalities in sEng-
expressing mice. Results of fluorescein angiography, Evans blue
extravasation, and western blotting for association of the tight
Figure 2. Inhibition of TGF-b decreases retinal perfusion and vascular autoregulation. After fourteen days of Ad-sEng and Ad-null
expression, mice were injected with h.m.w. FITC-dextran through the left ventricle to localize perfused vessels. (A) Confocal analysis of retinal flat-
mounts revealed reduced perfusion of the retina in the sEng-expressing mice compared to the control (representative photo of n=12 mice). Scale
bar=200 mm. (B) The perfused vessels were visualized on retinal flat mounts by comparing the co-localization of type IV collagen (Cy3-red) and FITC
and quantified on cryosections by comparing the number of vessels in the innermost vascular plexus (arrowheads) positive for both type IV collagen-
and FITC to the number of vessels positive for type IV collagen but negative for FITC (C). (D) The retinas of sEng expressing mice show a marked
reduction in the number of perfused vessels (n=5, ** p,0.01). (E) After seven days of adenoviral expression, blood flow rates in the tail were
measured non-invasively in response to intravascular injection of ACh. Measurements were made over 5 cycles pre-injection of ACh, normalized to 1
for each animal, and averaged at 5-cycle intervals post ACh injection. In Ad-null control mice, ACh increased tail vein blood flow rates 6–10 cycles
post-injection, whereas blood flow rates were unchanged in Ad-sEng expressing mice (Ad-null: 1.619 ml/cycle, n=5; Ad-sEng: 0.960 ml/cycle, n=4, *
p,0.01). Injection of 100 ml of saline in Ad-null or Ad-sEng mice elicited no response.
doi:10.1371/journal.pone.0005149.g002
TGF-b Signaling in the Retina
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days following adenovirus injection. Ad-sEng-expressing mice displayed increased retinal permeability compared to control mice. The increased
fluorescence leakage into the vitreous was observable at two min. Representative photographs are shown (n=4). (B) Experimental mice infected for
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b1 is required to maintain the BRB. In concordance with these
observations in vivo, coculture of ECs and 10T1/2 cells led to
enhanced EC barrier function, and the addition of the ALK5
inhibitor reversed this effect and reduced coculture-induced
association between occludin and zo-1. Furthermore, previous
reports demonstrate that systemic administration of a TGF-bR1
inhibitor (Calbiochem: LY364947) increases tumor vessel perme-
ability [44] and smad4 deficient mice exhibit defects in vascular
integrity and maturation as well as abnormal gap junction
formation [45]. Furthermore, the finding that permeability defects
in Akt(2/2) mice can be rescued with addition of TSP-1 and
TSP-2, both potent activators of TGF-b1 in vivo [46], further
support a role for TGF-b1 in the maintenance of the BRB. These
results suggest that locally activated TGF-b1 is critical for optimal
endothelial barrier function and are in agreement with our
previous reports demonstrating that TGF-b1 induced by astro-
cytes contacting ECs contributes to the maintenance of the blood-
neural-barrier [47].
While there was no change in the levels of the tight junction
proteins zo-1 and occludin in retinas from sEng-expressing mice
(data not shown), there was a decrease in association between these
proteins, a characteristic feature of tight junction disassembly [28].
Similarly, the coculture-induced association between occludin and
zo-1 was reversed with addition of the ALK-5 inhibitor. Integrity
of inter-endothelial junctions is regulated by multiple parameters
including cytoskeletal tension, junctional protein-protein interac-
tion and connection between junctional proteins and the actin
cytoskeleton. Each of these determine the intercellular cleft size
and degree of permeability. For example, binding of zo-1 to the
COOH-terminal cytoplasmic tail of occludin plays a role in
maintaining the tight junction and also cytoskeletal tethering [48],
whereas previous studies describe the association of occludin/zo-1
as dependent upon both tyrosine phosphatase signaling and also
protein kinase C [49].
High levels of circulating sEng also led to significant neural cell
apoptosis, particularly of the ganglion cells and neural cells of the
INL. The pattern of apoptotic cells correlated well with the
localization of pp-smad2, the direct downstream target of TGF-b1,
suggesting that the apoptosis and functional defects of neural
retinal cells are the direct effect of a role for TGF-b1 or TGF-b3a s
a survival factor. In support of this notion, TGF-b1 has been
described in the monkey and human ganglion cells of the retina,
the outer plexiform layer (OPL), the axon bundles in the nerve
fiber layer; and the associated ganglion cell bodies proximal to the
basal lamina comprising the inner limiting membrane [50]. The
TGF-b1 precursor molecule LC pre-pro is evident in the
photoreceptor outer segments, the OPL and Muller cell endfeet
cytoplasm. In normal adult rat retinas, both protein and mRNA of
TGF-bRI and TGF-bRII are present in the ganglion cells [51].
TGF-b3 is not associated with microvascular cells, but is present in
neural cells of the ganglion cell layer, the inner nuclear layer and
some photoreceptor cells. The expression of TGF-receptors and
pp-smad2 in normal retinas suggests that TGF-b plays an
important role in the homeostasis of normal retina [52], with
effects independent of the vasculature. These findings of impaired
retinal function with inhibition of TGF-b have important
implications for understanding both vasoproliferative and vascular
degenerative retinal diseases.
14 days were injected intravenously with 2% Evans blue in PBS, followed by systemic PBS perfusion 40 min later. The eyes were removed, retinas
dissected and quantified for Evans blue/albumin leakage. Inhibition of TGF-b resulted in a significant increase in the leakage of Evans blue into the
extravascular space (n=5, * p,0.05). (C) TEM micrographs of the inner retinal vasculature revealing tight junctions of Ad-null and sEng-expressing
mice (day 14). sEng mice displayed alterations in tight junction structure, with disturbed interdigitation between adjacent ECs (arrow), a reduction in
condensed regions characteristic of tight junctions and appearance of cellular debris between adjacent ECs (arrow). Scale=0.5 mm. (D)
Immunoprecipitation of occludin and western blotting for zo-1 demonstrated a significant decrease in association between occludin and zo-1 in
lysates prepared from retinas of sEng-expressing mice (day 7). Each lane corresponds to an individual mouse (n=4, * p,0.05).
doi:10.1371/journal.pone.0005149.g003
Figure 4. Co-culture of endothelial/mesenchymal cells acti-
vates endothelial smad2/3 signaling. (A) Transient transfection of
ECs with CAGA-Luc smad2/3 reporter revealed that co-culture with
10T1/2 cells activated smad2/3 signaling. Pharmacological inhibition of
TGF-b with 10 mM SB-431542 reversed this activation. (B) Co-culture of
ECs with 10T1/2 cells did not alter phosphorylation of EC smad1/5/8.
doi:10.1371/journal.pone.0005149.g004
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cobblestone morphology in EC monocultures. Co-culture enhanced the association between adjacent cells, which was reversed with addition of SB-
431542. Scale bars=100 mm (left panel); 10 mm (right panel). Cell size was calculated by tracing individual ECs using ImageJ. Morphology of 10T1/2
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RNA isolation and PCR
Retinas were dissected, and pooled for RNA extraction using a
RNAqueous - 4PCR kit (Ambion). RNA was reverse-transcribed
using Superscript II reverse transcriptase (Invitrogen). Standard
PCR was performed with 1 U Taq DNA polymerase (Roche
Diagnostics) and 0.2 mM of appropriate primer pair for 30 cycles.
Genes monitored were smad2, smad3, TGF-b1, TGF-b3 and
glyceraldehyde phosphate dehydrogenase (GAPDH). Primer pairs
(Invitrogen) used were smad2 (For: CGGAGATTCTAACA-
GAACTG; Rev: TGCTTGAGCATCGCACTGAA), smad3
(For: AGCACACAATAACTTGGACC; Rev: TAAGACA-
CACTGGAACAGCGGATG), TGF-b1 (For: GCTGCGCTT-
GCAGAGATTAAA; Rev: TTGCTGTACTGTGTGTCCAG),
TGF-b3 (For: GCTCTTCCAGATACTTCGAC; Rev: AG-
CAGTTCTCCTCCAGGTTG) and GAPDH (For: GTGG-
CAAAGTGGAGATGGTTGCC; Rev: GATGATGACCCG-
TTTGGCTCC). Following PCR, reaction products were ana-
lyzed by agarose gel electrophoresis on 2.5% gels with 100 bp
ladders as size standards, and visualization by ethidium bromide
staining.
Animals
All animal protocols were approved by the Schepens Eye
Research Institute IACUC and mice were handled in accordance
cells from cocultures with ECs was not visibly altered when compared to 10T1/2 monoculture or with the addition of SB431542. (B) Analysis of EC size
in monoculture or coculture with 10T1/2 cells (+/2SB431542). Coculture did not significantly alter average cell size, however, EC size were more
uniform when compared to EC mono-cultures. Addition of SB431542 led to larger and more heterogenous cell size.
doi:10.1371/journal.pone.0005149.g005
Figure 6. Inhibition of TGF-b impairs endothelial tight junction
protein association. (A) Assay of tight junction components in
Transwell cocultures of EC and 10T1/2 cells. Immunoprecipitation of
occludin and western blotting for zo-1 revealed a significant increase in
association between occludin and zo-1 in coculture compared to
monocultures (* p,0.05), which was reversed by the addition of SB-
431542. Non-specific IgG was used as a control for IP. (B) Assay of
permeability in Transwell cocultures. Coculture of BAECs with 10T1/2
cells increased EC barrier function as measured by decreased flux of
FITC-dextran from the upper to lower chamber. Addition of SB-431542
increased permeability of BAEC/10T1/2 cocultures.
doi:10.1371/journal.pone.0005149.g006
Figure 7. Ultrastructure of retinal vasculature following
inhibition of TGF-b. (A) TEM micrograph of a microvessel in the
ganglion cell layer from a retina of a control mouse expressing Ad-null
(day 14). Nuclei of an EC and pericyte are apparent, with a defined
basement membrane (arrow). (B)–(F) TEM micrographs of the retinal
vessels from mice expressing Ad-sEng. (B) The lining of some ECs
appeared ‘ruffled’ with finger-like processes protruding into the luminal
space and multiple vacuoles within the cytoplasmic space (arrow).
Nuclear condensation characteristic of apoptosis was apparent in some
(C) pericytes and (D) ECs (arrows). (E) (F) Numerous vessels in the inner
retinal layers displayed significant reductions in luminal diameter
(arrows). (A)–(F) Scale=2 mm.
doi:10.1371/journal.pone.0005149.g007
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and Vision Research. For in vivo neutralization of TGF-b, adult
CD-1 mice were injected via tail vein with 1610
‘10 viral particles
(VP) Ad-CMV-null (Ad-null) or 2.5610
‘9 VP Ad-CMV-sEng
(Ad-sEng) (Q Biogene, Montreal, Canada) with the day of
injection considered as day zero. Blood was collected in EDTA
tubes on day seven by submandibular vein or by cardiac puncture
on day 14 and plasma was collected and stored at 280uC. Plasma
sEng, measured via ELISA (R&D Systems, Minneapolis, MN),
was approximately 200 ng/ml seven days following injection.
Figure 8. Inhibition of TGF-b increases retinal cell apoptosis. (A) Following 14 days of infection with Ad-null or Ad-sEng, retinas were
examined for apoptotic cells via TUNEL staining. Retinas of sEng-expressing mice displayed a significant increase in the number of apoptotic cells. In
the control retinas, occasional cells of the inner nuclear layer (INL) could be marked as apoptotic (arrowheads). Positive control tissue sections were
treated with DNAse enzyme. Retinal sections were lightly counter-stained with hematoxylin QS to reveal nuclei (blue). Expression of sEng led to the
induction of apoptosis of most of the cells in both the ganglion cell layer (arrows) and in the INL (arrowheads). Scale=100 mm. (B) Lysates of whole
retinas were analyzed via western blotting for cleaved caspase 3 levels. Inhibition of TGF-b led to increased cleaved caspase 3 as compared to control
mice. (C) Quantification of (B) (* p,0.05).
doi:10.1371/journal.pone.0005149.g008
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Cell pellets were treated with lysis buffer and equal protein was
fractionated by 10% (wt/vol) polyacrylamide resolving gels. After
transfer to nitrocellulose membranes, non-specific protein binding
was blocked by a 60-min incubation in PBS-T (phosphate-buffered
saline, 0.1% Tween-20) containing 5% (wt/vol) nonfat skim milk.
Membranes were then incubated overnight at 4uC with either pp-
smad2 (1:100; Chemicon, Temecula, CA) or caspase 3 (1:100; Cell
Signaling) antibodies diluted in PBS-T with 2.5% BSA. After two
10-min washes with PBS-T, membranes were incubated with
horseradish peroxidase–conjugated rabbit polyclonal IgG anti-
body (1:300) for 90 min at room temperature. After two further
washes with PBS-T, immunoreactive proteins were identified by
enhanced chemiluminescence. Scanning densitometry was per-
formed with image-analysis software (ImageJ).
Changes in occludin/zo-1 co-association were monitored by
immunoprecipitation, performed as previously described [53] with
minor modifications. Cells lysates (50 mg) were incubated with
1.75 mg of anti-occludin antibody (final volume of 500 ml) and
incubated overnight at 4uC with continuous rotation. Complexes
were captured with 50 ml protein A beads (50% slurry; Upstate),
washed in PBS, resuspended in 25 ml of SDS-PAGE sample buffer
and heated for 5 min at 90uC. Beads were pelleted and
supernatant examined by Western blotting as described above
with anti-zo-1 antibodies (1:500; Zymed).
Immunohistochemistry
Cryosections were blocked with 0.2% Tween, 3% donkey
serum and 3% goat serum in PBS (Sigma, St Louis, MO), then
incubated overnight at 4uC with primary antibodies diluted in
blocking solution (pp-smad2, 1:500; Chemicon, Temecula, CA).
Secondary antibody of biotin-conjugated goat anti-rabbit (Vector
Labs, Burlingame, CA) were added, and were visualized with
avidin-biotin-peroxidase technique and 3, 39-diaminobenzidine
(DAB) substrates (Vector ABC kit). Each experiment included a
section incubated with isotope-matched IgG as a negative control.
Images were captured with a Zeiss Axioskop 2 MOT plus
microscope.
Fluorescein perfusion
Following 14 days of infection, mice were perfused with seven
ml of fluorescein dextran 2610
‘6 m.w. (Sigma, St Louis, MO)
(50 mg/ml in 4% paraformaldehyde) in PBS pre-warmed to 37uC.
Perfusion was accomplished from a 21-gauge cannula inserted into
the aorta via the left ventricle, allowing blood and fixative to exit
via an opening in the right atrium. Tissues were removed, fixed in
4% paraformaldehyde at 4uC overnight and processed for
cryosections or retinas were isolated and flat-mounted for
visualization by confocal fluorescence microscopy using a Leica
TCS Sp2 confocal microscope. Composites were generated using
Adobe Photoshop.
Quantification of vascular perfusion
Cryosections (10 mm) of retinas from mice perfused with FITC-
dextran were blocked overnight at 4uC (in PBS, 0.2% Tween, 3%
donkey serum and 3% goat serum), then incubated at 4uC
overnight with rabbit anti-collagen type IV polyclonal (1:400;
Abcam, Cambridge, MA) followed by a rhodamine-conjugated
anti-rabbit secondary antibody (1:300; Jackson Immunoresearch,
West Grove, PA). Perfusion of retinal vessels in the ganglion cell
layer was measured by comparing the number of collagen IV-
positive vessels to the number of FITC positive vessels on
successive cryosections. For each animal, three cryosections
separated by 150 mm were quantified.
Blood flow autoregulation
To assess peripheral autoregulation capacity, flow rates (ml/
cycle) were measured in the tail using a CODA 6 non-invasive
blood pressure system (Kent Scientific, Torrington, CT) under 2%
isoflurane anesthesia. Seven days post injection, baseline flow rates
were established in Ad-null or Ad-sEng mice, before measuring
vasoactive response to retro-orbital injection of 12.5 mg/kg
acetylcholine (Ach) (total volume 100 ml), an endothelium
dependent vasodilator.
Fundus angiography
Seven days after adenovirus injection, mice were anesthetized
and their pupils dilated with 1% atropine sulfate. Fluorescein
angiography was performed after intraperitoneal injection of
0.05 ml of 25% fluorescein sodium (Akron). Photographs were
taken with a preset 20D lens appositioned to the fundus camera
lens at regular time (from 1 min to 4 min post I.P injection).
Evans blue permeability
Vascular permeability was assessed using Evans Blue as
previously described [17]. Seven days after injection, mice were
anesthetized and injected via tail vein with 2% Evans Blue dye.
After 40 min mice were perfused via heart puncture with PBS
containing 2 mM EDTA for 20 min. Retinas were harvested and
incubated in formamide and rotated at 70uC for 24 hr.
Supernatants containing extravascular Evans blue were collected
after centrifugation at 14,000 rpm for 10 min. The optical density
(OD) was measured at 620 nm. The following formula was used to
correct OD for contamination with heme pigments: OD620
(corrected)=OD6202(1.3266OD740+0.030).
Transmission electron microscopy (TEM)
Following 14 days of adenoviral infection, mice were perfused
with fluorescein as described above except that 10 ml sodium
cacodylate buffer 0.2 M, pH 7.4, followed by 10 ml of half
strength Karnovsky’s fixative was used. Retinas were dissected and
fixed with half strength Karnovsky’s fixative, followed by 2%
osmium tetroxide and en block stain with 0.5% uranyl acetate.
After dehydration and embedding, ultra-thin sections were
visualized using a Phillips 410 transmission electron microscope.
Scanning electron microscopy (SEM)
Transwell cultures were washed in PBS and fixed in half-
strength Karnovsky fixative, rinsed in PBS and dehydrated in a
Figure 9. Inhibition of TGF-b leads to functional and morphological changes in retinal neural cells. (A) Following seven days of infection
with Ad-null or Ad-sEng, retinal function was examined by scotopic ERG recording. (B) Inhibition of TGF-b did not alter the a-wave response, however
b-wave was significantly decreased in Ad-sEng mice (n=5, * p,0.05). (C) TEM of retinas from mice expressing Ad-null or Ad-sEng (day 14). Ganglion
cells of sEng-expressing mice displayed features characteristic of apoptosis, with condensed nuclei (white arrow), cellular shrinkage and separation
from surrounding extracellular matrix. Microvessels in Ad-null-infected mice appear normal in GCL and in the INL. Apoptosis was evident in the INL of
sEng-expressing mice with separation of cells from surrounding tissue creating empty spaces (arrows) and apoptosis was apparent in the ONL of
some sEng-expressing mice. Scale=5 mm.
doi:10.1371/journal.pone.0005149.g009
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PLoS ONE | www.plosone.org 14 April 2009 | Volume 4 | Issue 4 | e5149graded series of ethanol solutions. After drying in a critical point
dryer (Samdri-795; Tousimis, Rockville, MD), samples were
coated with a 150A carbon layer (Ion Beam Coater; Gatan,
Pleasanton, CA). Cell images were captured on a scanning
electron microscope (FESEM 7401F; Field-Emission Scanning
Electron Microscope; JEOL, Peabody, MA) using backscatter
detection to visualize the gold labeling.
Cell culture
For cocultures, 10T1/2 cells were cultured on the underside of
Transwell inserts (0.4 mm pore size, Co-star) for four days at
confluence before addition of BAECs and culture for a further
three days in DMEM 10% FBS. The TGF-b signaling inhibitor,
SB-431542 (Tocris) (10 mM), which inhibits ALK5, but not ALK1,
kinase activity, [54] was added in DMEM containing 1% FBS for
24 hr. Control wells contained equivalent volumes of DMSO.
For 3 dimensional cocultures, 8.0610
4 BAECs and 2.0610
4
10T1/2 cells were cocultured for five days in 400 ul of 50%
Matrigel
TM(BD Biosciences) in 10% FBS, 40% DMEM, 10 ng/ml
VEGF (obtained from the NIH-NCI Preclinical Repository).
Media containing 10% FBS overlaid each gel. To distinguish
between the two cell types, 10T1/2 cells were pre-labeled with
PKH26 red fluorescent linker dye (Sigma, St Louis, MO). To
examine effects of ALK5 inhibition, 10 mM SB-431542 was added
for 72 hr in DMEM containing 1% FBS. Control gels were treated
with equivalent amounts of DMSO. Apoptotic cells were detected
using the VybrantH Apoptosis Assay Kit (Invitrogen, Carlsbad,
CA) followed by FACS analysis using a FACSCAN flow
cytometer.[55] Cells were retrieved from Matrigel with BD cell
recovery solution (BD Biosciences) as per the manufacturer’s
instructions.
Transendothelial permeability assay
BAECs-10T1/2’s were grown on Transwell filters in the
presence or absence of SB-431542 (10 mM). FITC-dextran
(0.5 mg/ml; 40 kDa; Sigma, St Louis, MO) was added to the
upper chamber. Aliquots (100 ml) were collected over time from
the lower chamber (5, 15, 30, 60, 120, 240 min). The liquid
volume and hydrostatic pressure in the lower chamber were
maintained by replenishing 100 ul of media (+/2SB-431542) to
the lower chamber at each time point. Fluorescence measurements
were determined immediately using a fluorescence reader
(excitation maximum 490 nm; emission maximum: 520 nm).
Electroretinogram recording (ERG)
Retinal function was assessed using a UTAS-E3000 recording
system (LKC, Technologies, Inc. Gaithersburg, MD). Mice were
dark-adapted for 6 hr and anesthetized with a mixture of
ketamine/xylazine (120 mg/kg and 10 mg/kg, respectively).
Pupils were dilated with drops of 1% tropicamide and 1.5%
cyclopentolate. The active electrode was a gold wire loop on the
cornea, the reference electrode was placed in the head, and the
ground electrode was placed in the back. Each mouse was placed
in front of a Ganzfeld bowl (UTAS3000; LKC Technologies) that
presented a series of flashes with increasing intensity. ERG
response to a series of increasing intensity light flashes: +10-dB was
averaged over 10 separate flashes per light intensity. The inter-
stimulus interval was 1 minute for all flash intensities. The a-wave
amplitude was measured from the baseline to the trough of the first
negative wave and the b-wave amplitude was measured from the
trough of the a-wave to the peak of the positive wave or when the
a-wave was not present, from baseline to the peak of the positive
wave.
TUNEL assay
Apoptotic cells were detected using the Promega Dead End
HRP kit (Promega, Madison, WI), following the manufacturer’s
procedure with some modifications. Sections were permeabi-
lized for 5 min in cold PBS containing 0.2% Tween-20, then
pre-equilibrated with equilibration buffer and incubated at
37uC in TUNEL reaction mix containing biotinylated nucle-
otides and TdT (terminal deoxynucleotidyl transferase) en-
zyme. The reaction was terminated after 1 hr with 26 SSC
solution for 15 min at RT. Biotinylated nucleotides were
detected by incubation with Strepavidine-HRP followed by
DAB incubation. Staining was stopped by washing in PBS and
sections were lightly counterstained with hematoxylin prior to
mounting.
Statistical analysis
In all experiments, unless otherwise indicated, data are reported
as mean6SD in at least 3 replicates per group. Data were
analyzed by student’s unpaired T-Test. P values ,0.05 were taken
to indicate statistical significance.
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Figure 10. Inhibition of TGF-b signaling in EC-10T1/2 cell coculture leads to increased EC apoptosis. (A–B) Transwell cocultures of BAECs
and 10T1/2 cells in the presence and absence of SB-431542, an inhibitor of ALK5. (A) Coculture of BAEC and 10T1/2 did not alter baseline levels of
BAEC apoptosis. Addition of SB-431542 led to a significant increase in BAEC apoptosis in cocultures, but not monocultures. (B) Culture of 10T1/2 cells
in the presence of BAECs significantly decreased baseline rates of 10T1/2 cell apoptosis. Addition of SB-431542 did not alter 10T1/2 cell apoptosis in
either monoculture or in coculture with BAECs. Addition of SB-431542 increased cleavage of EC caspase 3 in co-culture with 10T1/2 cells (C) whereas
the anti-apoptotic BCl-xl decreased (D). (E) Coculture of BAECs (unlabelled) in direct coculture with 10T1/2 cells (red) led to the formation of tube-like
structures by EC, with 10T1/2 cells wrapped around and in close association with tubes. Addition of SB-431542 to BAEC-10T1/2 cocultures, after tubes
had formed, led to the dissociation of 10T1/2 cells from the ECs and disassembly of tube-like structures. (F) Annexin V FACs assay for apoptosis of
BAECs and 10T1/2 cells from (E) demonstrated a significant increase in EC apoptosis. Cells were retrieved using Matrigel dissociation solution and
distinguished as red (10T1/2) or unlabeled (BAEC). Baseline apoptotic rates of both cell types in Matrigel are high as the cells that do not form tubes
remain in the matrix and undergo apoptosis. Each experiment is representative of at least three independent experiments with similar results.
doi:10.1371/journal.pone.0005149.g010
TGF-b Signaling in the Retina
PLoS ONE | www.plosone.org 15 April 2009 | Volume 4 | Issue 4 | e5149References
1. Ten Dijke P, Arthur HM (2007) Extracellular control of TGFbeta signalling in
vascular development and disease. Nat Rev Mol Cell Biol 8: 857–869.
2. Antonelli-Orlidge A, Saunders KB, Smith SR, D’Amore PA (1989) An activated
form of transforming growth factor beta is produced by cocultures of endothelial
cells and pericytes. Proc Natl Acad Sci U S A 86: 4544–4548.
3. Hirschi KK, Rohovsky SA, D’Amore PA (1998) PDGF, TGF-beta, and
heterotypic cell–cell interactions mediate endothelial cell-induced recruitment of
10T1/2 cells and their differentiation to a smooth muscle fate. J Cell Biol 141:
805–814.
4. Neubauer K, Kruger M, Quondamatteo F, Knittel T, Saile B, et al. (1999)
Transforming growth factor-beta1 stimulates the synthesis of basement
membrane proteins laminin, collagen type IV and entactin in rat liver sinusoidal
endothelial cells. J Hepatol 31: 692–702.
5. Engerman RL, Pfaffenbach D, Davis MD (1967) Cell turnover of capillaries.
Lab Invest 17: 738–743.
6. Stewart PA, Tuor UI (1994) Blood-eye barriers in the rat: correlation of
ultrastructure with function. J Comp Neurol 340: 566–576.
7. Shepro D, Morel NM (1993) Pericyte physiology. Faseb J 7: 1031–1038.
8. Murphy-Ullrich JE, Poczatek M (2000) Activation of latent TGF-beta by
thrombospondin-1: mechanisms and physiology. Cytokine & Growth Factor
Reviews 11: 59–69.
9. Hammes HP (2005) Pericytes and the pathogenesis of diabetic retinopathy.
Horm Metab Res 37 Suppl 1: 39–43.
10. Lebrin F, Deckers M, Bertolino P, Ten Dijke P (2005) TGF-beta receptor
function in the endothelium. Cardiovasc Res 65: 599–608.
11. Lebrin F, Goumans MJ, Jonker L, Carvalho RL, Valdimarsdottir G, et al. (2004)
Endoglin promotes endothelial cell proliferation and TGF-beta/ALK1 signal
transduction. Embo J 23: 4018–4028.
12. Thorpe PE (2004) Vascular targeting agents as cancer therapeutics. Clin Cancer
Res 10: 415–427.
13. Pepper MS (1997) Transforming growth factor-beta: vasculogenesis, angiogen-
esis, and vessel wall integrity. Cytokine Growth Factor Rev 8: 21–43.
14. Dickson MC, Martin JS, Cousins FM, Kulkarni AB, Karlsson S, et al. (1995)
Defective haematopoiesis and vasculogenesis in transforming growth factor-beta
1 knock out mice. Development 121: 1845–1854.
15. Larsson J, Goumans MJ, Sjostrand LJ, van Rooijen MA, Ward D, et al. (2001)
Abnormal angiogenesis but intact hematopoietic potential in TGF-beta type I
receptor-deficient mice. Embo J 20: 1663–1673.
16. Guttmacher AE, Marchuk DA, White RI Jr (1995) Hereditary hemorrhagic
telangiectasia. N Engl J Med 333: 918–924.
17. Venkatesha S, Toporsian M, Lam C, Hanai J, Mammoto T, et al. (2006) Soluble
endoglin contributes to the pathogenesis of preeclampsia. Nat Med 12: 642–649.
18. Brown MA, Zammit VC, Lowe SA (1989) Capillary permeability and
extracellular fluid volumes in pregnancy-induced hypertension. Clin Sci (Lond)
77: 599–604.
19. van Royen N, Hoefer I, Buschmann I, Heil M, Kostin S, et al. (2002) Exogenous
application of transforming growth factor beta 1 stimulates arteriogenesis in the
peripheral circulation. Faseb J 16: 432–434.
20. Darland DC, D’Amore PA (2001) TGF beta is required for the formation of
capillary-like structures in three-dimensional cocultures of 10T1/2 and
endothelial cells. Angiogenesis 4: 11–20.
21. Gordon-Thomson C, de Iongh RU, Hales AM, Chamberlain CG, McAvoy JW
(1998) Differential cataractogenic potency of TGF-beta1, -beta2, and -beta3 and
their expression in the postnatal rat eye. Investigative Ophthalmology & Visual
Science 39: 1399–1409.
22. Gue ´rin CJ, Hu L, Scicli G, Scicli AG (2001) Transforming growth factor beta in
experimentally detached retina and periretinal membranes. Experimental Eye
Research 73: 753–764.
23. Lutty GA, Merges C, Threlkeld AB, Crone S, McLeod DS (1993) Heterogeneity
in localization of isoforms of TGF-beta in human retina, vitreous, and choroid.
Invest Ophthalmol Vis Sci 34: 477–487.
24. Watabe T, Nishihara A, Mishima K, Yamashita J, Shimizu K, et al. (2003)
TGF-beta receptor kinase inhibitor enhances growth and integrity of embryonic
stem cell-derived endothelial cells. J Cell Biol 163: 1303–1311.
25. Li H, Wallerath T, Forstermann U (2002) Physiological mechanisms regulating
the expression of endothelial-type NO synthase. Nitric Oxide 7: 132–147.
26. Nagaoka T, Sakamoto T, Mori F, Sato E, Yoshida A (2002) The effect of nitric
oxide on retinal blood flow during hypoxia in cats. Invest Ophthalmol Vis Sci
43: 3037–3044.
27. Henry E, Newby DE, Webb DJ, O’Brien C (1999) Peripheral endothelial
dysfunction in normal pressure glaucoma. Invest Ophthalmol Vis Sci 40:
1710–1714.
28. Collins NT, Cummins PM, Colgan OC, Ferguson G, Birney YA, et al. (2006)
Cyclic strain-mediated regulation of vascular endothelial occludin and ZO-1:
influence on intercellular tight junction assembly and function. Arterioscler
Thromb Vasc Biol 26: 62–68.
29. Wachtmeister L, Dowling JE (1978) The oscillatory potentials of the mudpuppy
retina. Invest Ophthalmol Vis Sci 17: 1176–1188.
30. Jeon CJ, Strettoi E, Masland RH (1998) The major cell populations of the mouse
retina. J Neurosci 18: 8936–8946.
31. Fernandez-L A, Fernandez-Lopez A, Garrido-Martin EM, Sanz-Rodriguez F,
Pericacho M, et al. (2007) Gene expression fingerprinting for human hereditary
hemorrhagic telangiectasia. Hum Mol Genet 16: 1515–1533.
32. Schonfelder U, Hofer A, Paul M, Funk RH (1998) In situ observation of living
pericytes in rat retinal capillaries. Microvasc Res 56: 22–29.
33. Furukawa H (1987) Autonomic innervation of preretinal blood vessels of the
rabbit. Invest Ophthalmol Vis Sci 28: 1752–1760.
34. Hirschi KK, Rohovsky SA, Beck LH, Smith SR, D’Amore PA (1999)
Endothelial cells modulate the proliferation of mural cell precursors via
platelet-derived growth factor-BB and heterotypic cell contact. Circ Res 84:
298–305.
35. Sato Y, Rifkin DB (1989) Inhibition of endothelial cell movement by pericytes
and smooth muscle cells: activation of a latent transforming growth factor-beta
1-like molecule by plasmin during co-culture. J Cell Biol 109: 309–315.
36. Seki T, Yun J, Oh SP (2003) Arterial endothelium-specific activin receptor-like
kinase 1 expression suggests its role in arterialization and vascular remodeling.
Circ Res 93: 682–689.
37. Lu Q (2008) Transforming Growth Factor-{beta}1 Protects Against Pulmonary
Artery Endothelial Cell Apoptosis via ALK5. Am J Physiol Lung Cell Mol
Physiol.
38. Merwin JR, Anderson JM, Kocher O, Van Itallie CM, Madri JA (1990)
Transforming growth factor beta 1 modulates extracellular matrix organization
and cell–cell junctional complex formation during in vitro angiogenesis. J Cell
Physiol 142: 117–128.
39. Urase K, Momoi T, Fujita E, Isahara K, Uchiyama Y, et al. (1999) Bcl-xL is a
negative regulator of caspase-3 activation in immature neurons during
development. Brain Res Dev Brain Res 116: 69–78.
40. Darland DC, Massingham LJ, Smith SR, Piek E, Saint-Geniez M, et al. (2003)
Pericyte production of cell-associated VEGF is differentiation-dependent and is
associated with endothelial survival. Dev Biol 264: 275–288.
41. Ramsauer M, D’Amore PA (2007) Contextual role for angiopoietins and
TGFbeta1 in blood vessel stabilization. J Cell Sci 120: 1810–1817.
42. Frank R, Adelmann-Grill BC, Herrmann K, Haustein UF, Petri JB, et al. (1996)
Transforming growth factor-beta controls cell-matrix interaction of microvas-
cular dermal endothelial cells by downregulation of integrin expression. J Invest
Dermatol 106: 36–41.
43. Pfeiffer A, Spranger J, Meyer-Schwickerath R, Schatz H (1997) Growth factor
alterations in advanced diabetic retinopathy: a possible role of blood retina
barrier breakdown. Diabetes 46 Suppl 2: S26–30.
44. Kano MR, Bae Y, Iwata C, Morishita Y, Yashiro M, et al. (2007) Improvement
of cancer-targeting therapy, using nanocarriers for intractable solid tumors by
inhibition of TGF-beta signaling. Proc Natl Acad Sci U S A 104: 3460–3465.
45. Lan Y, Liu B, Yao H, Li F, Weng T, et al. (2007) Essential role of endothelial
smad4 in vascular remodeling and integrity. Mol Cell Biol 27: 7683–7692.
46. Chen J, Somanath PR, Razorenova O, Chen WS, Hay N, et al. (2005) Akt1
regulates pathological angiogenesis, vascular maturation and permeability in
vivo. Nat Med 11: 1188–1196.
47. Garcia CM, Darland DC, Massingham LJ, D’Amore PA (2004) Endothelial cell-
astrocyte interactions and TGF beta are required for induction of blood-neural
barrier properties. Brain Res Dev Brain Res 152: 25–38.
48. Mitic LL, Schneeberger EE, Fanning AS, Anderson JM (1999) Connexin-
occludin chimeras containing the ZO-binding domain of occludin localize at
MDCK tight junctions and NRK cell contacts. J Cell Biol 146: 683–693.
49. Collins NT, Cummins P, Colgan OC, Ferguson G, Birney Y, et al. (2006) Cyclic
strain-mediated regulation of vascular endothelial occludin and ZO-1: influence
on intercellular tight junction assembly and function. Arteriosclerosis, Throm-
bosis, and Vascular Biology 26: 62–68.
50. Anderson DH, Guerin CJ, Hageman GS, Pfeffer BA, Flanders KC (1995)
Distribution of transforming growth factor-beta isoforms in the mammalian
retina. J Neurosci Res 42: 63–79.
51. Ma L, Cantrup R, Varrault A, Colak D, Klenin N, et al. (2007) Zac1 functions
through TGFbetaII to negatively regulate cell number in the developing retina.
Neural Develop 2: 11.
52. Yamanaka R, Ogata N, Yamamoto C, Matsushita M, Matsuzaki K, et al. (2002)
Expression of transforming growth factor-beta receptors in normal rat retina and
experimental choroidal neovascularization. Jpn J Ophthalmol 46: 525–532.
53. Ferguson G, Watterson KR, Palmer TM (2000) Subtype-specific kinetics of
inhibitory adenosine receptor internalization are determined by sensitivity to
phosphorylation by G protein-coupled receptor kinases. Mol Pharmacol 57:
546–552.
54. Goumans MJ, Valdimarsdottir G, Itoh S, Lebrin F, Larsson J, et al. (2003)
Activin receptor-like kinase (ALK)1 is an antagonistic mediator of lateral
TGFbeta/ALK5 signaling. Mol Cell 12: 817–828.
55. Gao W, Ferguson G, Connell P, Walshe T, Murphy R, et al. (2007) High
glucose concentrations alter hypoxia-induced control of vascular smooth muscle
cell growth via a HIF-1alpha-dependent pathway. J Mol Cell Cardiol 42:
609–619.
TGF-b Signaling in the Retina
PLoS ONE | www.plosone.org 16 April 2009 | Volume 4 | Issue 4 | e5149